Deutsche Bank Ag\ Foghorn Therapeutics Inc. Transaction History

Deutsche Bank Ag\

$218 Billion
Q2 2024

A detailed history of Deutsche Bank Ag\ transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 7,840 shares of FHTX stock, worth $63,268. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,840

Previous 9,594 18.28%

Holding current value

$63,268

Previous $64,000 29.69%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$5.05 - $8.0 $8,857 - $14,032	-1,754 Reduced 18.28%	7,840 $45,000
Q1 2024 May 15, 2024	SELL	$2.82 - $7.94 $1,125 - $3,168	-399 Reduced 3.99%	9,594 $64,000
Q2 2023 Aug 14, 2023	SELL	$5.37 - $8.84 $16,034 - $26,396	-2,986 Reduced 23.01%	9,993 $70,000
Q1 2023 May 15, 2023	BUY	$4.66 - $8.99 $20,224 - $39,016	4,340 Added 50.24%	12,979 $80,000
Q4 2022 Feb 13, 2023	BUY	$5.44 - $9.46 $739 - $1,286	136 Added 1.6%	8,639 $55,000
Q3 2022 Nov 14, 2022	SELL	$7.52 - $18.01 $10,114 - $24,223	-1,345 Reduced 13.66%	8,503 $73,000
Q2 2022 Aug 11, 2022	SELL	$8.48 - $16.84 $6,605 - $13,118	-779 Reduced 7.33%	9,848 $134,000
Q1 2022 May 13, 2022	SELL	$8.87 - $22.1 $11,158 - $27,801	-1,258 Reduced 10.58%	10,627 $162,000
Q4 2021 Feb 11, 2022	SELL	$10.79 - $22.87 $896,163 - $1.9 Million	-83,055 Reduced 87.48%	11,885 $272,000
Q3 2021 Nov 04, 2021	SELL	$8.33 - $15.02 $784,427 - $1.41 Million	-94,169 Reduced 49.8%	94,940 $1.32 Million
Q2 2021 Aug 11, 2021	SELL	$9.32 - $13.26 $315,062 - $448,254	-33,805 Reduced 15.17%	189,109 $2.02 Million
Q1 2021 May 13, 2021	BUY	$11.8 - $23.11 $2.57 Million - $5.03 Million	217,868 Added 4317.64%	222,914 $2.94 Million
Q4 2020 Feb 16, 2021	BUY	$15.12 - $25.88 $76,295 - $130,590	5,046 New	5,046 $102,000

Others Institutions Holding FHTX

# of Institutions

Shares Held

32.7M

Call Options Held

Put Options Held

1.8K

View Full List

About Foghorn Therapeutics Inc.

Ticker FHTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,637,400
Market Cap $336M
Description
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...

More about FHTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account